Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Sezary Syndrome × Aprepitant × Clear all

Phase

Phase NA 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 8 Nausea 4 Lymphoma 3 Breast Neoplasms 3 Neoplasms 2 Leukemia 2 Uterine Neoplasms 1 Thyroid Neoplasms 1 Sezary Syndrome 1 Pruritus 1 Post-Dural Puncture Headache 1 Ovarian Neoplasms 1 Hematologic Neoplasms 1

Interventions

denileukin diftitox 2 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01625455 2017-05-10

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

Vanderbilt University Medical Center

Phase 4 Terminated

7 enrolled 7 charts

Pruritus, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡